|Articles|December 1, 2014
- Applied Clinical Trials-12-01-2014
- Volume 23
- Issue 12
Applied Clinical Trials Digital Edition - December 2014/January 2015
The Future of ePRO Collection Mobile Customization Strategies Academic Research and CTMS Also in this issue: New Combination Drug Challenges Clinical Research Perceptions in Europe Key Benefits of Investigator Portals
Advertisement
Articles in this issue
almost 11 years ago
How Mobile Technology is Evolving in Clinical Trialsalmost 11 years ago
The Cost to Develop an Approved New Drug Now Exceeds $2.5Balmost 11 years ago
The Future of ePRO Platformsalmost 11 years ago
Sponsors Face New Challenges in Developing Combination Drugsalmost 11 years ago
Health Challenges Mount for Europealmost 11 years ago
Clinical Document Exchange Portals: Trendy or Revolutionary?almost 11 years ago
Steps for a Successful Clinical Trial Management Systemalmost 11 years ago
DIA Opts for Paris in the SpringtimeNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Eli Lilly’s Phase II Trial of Eloralintide Shows Up to 20% Weight Reduction in Adults With Obesity
2
Novo Nordisk’s Phase III OASIS 4 Analyses Highlight Cardiometabolic Benefits of Oral Semaglutide 25 mg
3
Designing Feasible Protocols with Real-World Data
4
FDA Approves UCB’s Kygevi for TK2 Deficiency Based on Multi-Study Clinical Program Demonstrating Significant Survival and Motor Gains
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
